Immunotech Biopharm Ltd
Company Profile
Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHNT: +86 1088400152
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
202
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,557.40 | 11.70 | -0.14% |
CAC 40 | 7,716.54 | 81.80 | 1.07% |
DAX 40 | 20,874.18 | 218.79 | 1.06% |
Dow JONES (US) | 43,153.13 | 68.42 | -0.16% |
FTSE 100 | 8,508.03 | 116.13 | 1.38% |
HKSE | 19,584.06 | 61.17 | 0.31% |
NASDAQ | 19,338.29 | 172.95 | -0.89% |
Nikkei 225 | 38,451.46 | 121.14 | -0.31% |
NZX 50 Index | 13,130.43 | 129.76 | 1.00% |
S&P 500 | 5,937.34 | 12.57 | -0.21% |
S&P/ASX 200 | 8,310.40 | 16.60 | -0.20% |
SSE Composite Index | 3,241.82 | 5.79 | 0.18% |